Daiwa Securities Group Inc. Kala Pharmaceuticals, Inc. Transaction History

Daiwa Securities Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$1.16 - $2.74 $121 - $287	-105 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$6.28 - $8.79 $659 - $922	105 New	105 $1,000
Q4 2019 Jan 31, 2020	SELL	$3.36 - $4.81 $456 - $654	-136 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$12.26 - $18.98 $1,667 - $2,581	136 New	136 $2,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.08M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.